In the news release, Encoura and Element451 Announce Strategic Partnership to Close Higher Ed's Gap Between Data Intelligence and Real-Time Action, issued 03-Jun-2026 by...
Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary — Fusion has been "thirty years away" for...
Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Fusion has been "thirty years away" for...
Seasoned finance executive brings deep experience scaling growth-stage companies and advancing strategic commercializationWOODBRIDGE, Conn., June 3, 2026 /PRNewswire/ -- P2 Science, Inc., a leading green...
ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development...
ExxonMobil, Eli Lilly, Johnson & Johnson, and Sinopec headline a two-day program where petrochemicals, pharma, and the energy transition convergeHOUSTON, June 3, 2026 /PRNewswire/...
STOCKHOLM, June 3, 2026 /PRNewswire/ -- Hygiene and health company Essity has once again been recognized for its leadership in sustainability by the global...
STOCKHOLM, June 3, 2026 /PRNewswire/ -- Hygiene and health company Essity has once again been recognized for its leadership in sustainability by the global...
Actor Kate Walsh to join Oceana in Mombasa at Our Ocean Conference to meet with local fishers and elevate coastal voices in global ocean decision making
Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease.